Cite
MLA Citation
C. Abboud et al.. “P501: CLI120-001 PHASE1B DOSE ESCALATION STUDY OF RVU120 IN PATIENTS WITH AML OR HIGH RISK MDS SAFETY AND EFFICACY DATA UPDATE.” HemaSphere, vol. 6, n.d., pp. 400–401. http://access.bl.uk/ark:/81055/vdc_100158014036.0x00000e